| __timestamp | BioCryst Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 2614539000 |
| Thursday, January 1, 2015 | 46361000 | 3711019000 |
| Friday, January 1, 2016 | 23654000 | 4560733000 |
| Sunday, January 1, 2017 | 23484000 | 5475166000 |
| Monday, January 1, 2018 | 20182000 | 6276700000 |
| Tuesday, January 1, 2019 | 44734000 | 7081200000 |
| Wednesday, January 1, 2020 | 16136000 | 7377200000 |
| Friday, January 1, 2021 | 149906000 | 13634200000 |
| Saturday, January 1, 2022 | 264233000 | 10612500000 |
| Sunday, January 1, 2023 | 326751000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have showcased contrasting trajectories in gross profit over the past decade. From 2014 to 2023, Regeneron has consistently outperformed BioCryst, with its gross profit peaking at over $13.6 billion in 2021, a staggering 4,000% higher than BioCryst's peak in 2023. This disparity highlights Regeneron's robust market position and successful product pipeline.
BioCryst, while showing growth, particularly in recent years, remains a smaller player. Its gross profit increased by over 2,300% from 2014 to 2023, indicating potential for future expansion. The data underscores the importance of strategic innovation and market adaptation in the biotech sector. As these companies continue to evolve, investors and industry watchers should keep a keen eye on their financial health and strategic moves.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Regeneron Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Novartis AG and BioCryst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Grifols, S.A. vs BioCryst Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown